Forth Therapeutics

Forth Therapeutics was founded in 2025, is headquartered in Edinburgh, United Kingdom, lists 1–10 employees, and has $4.7M in recorded funding across 1 round.

Headquarters
Edinburgh
Employees
1–10
Founded
2025
Business Model
B2B
Total Funding
$4.7M
Last Round
$4.7M SeedMar 2025
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 2 investors for this company. The full record is or through the API.

About

Forth Therapeutics is a precision biotech company developing therapeutics that target the underlying mechanisms driving fibrotic and inflammatory diseases. The company was spun out of the University of Edinburgh in early 2025, built on pioneering research from Professor Neil Henderson, a world-renowned expert in liver fibrosis. Using multi-omic insights from patient-derived tissue samples — including single-cell and spatial genomics — Forth has built one of the largest single-cell human liver disease datasets in the world, which it uses to identify antifibrotic drug targets with high precision. Headquartered in Edinburgh and Cambridge, the company is led by CEO Alex Leech, a serial entrepreneur and partner at lead investor Sofinnova Partners.

Summary

Forth Therapeutics is a Biotech company based in Edinburgh, United Kingdom, founded in 2025. It lists 1–10 employees. It has raised $4.7M in total across 1 round, most recently a $4.7M Seed round in Mar 2025. Investors include Sofinnova Partners and Old College Capital.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedSeed RoundMar 2025
$4.7M

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Forth Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/forth-therapeutics"><img src="https://indexed.vc/api/badge/company/forth-therapeutics" alt="Forth Therapeutics on Indexed.vc" width="260" height="76" /></a>